These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23271795)

  • 1. Do ingredients make the difference?: finding the best cocktail of an anticoagulant with antiplatelets.
    Sinnaeve PR; Van de Werf F
    Circulation; 2013 Feb; 127(5):566-8. PubMed ID: 23271795
    [No Abstract]   [Full Text] [Related]  

  • 2. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
    Dans AL; Connolly SJ; Wallentin L; Yang S; Nakamya J; Brueckmann M; Ezekowitz M; Oldgren J; Eikelboom JW; Reilly PA; Yusuf S
    Circulation; 2013 Feb; 127(5):634-40. PubMed ID: 23271794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
    Belavic JM
    Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210
    [No Abstract]   [Full Text] [Related]  

  • 4. Warfarin: is the end nigh? Please?
    Neilson RF
    J R Coll Physicians Edinb; 2010 Sep; 40(3):222-3. PubMed ID: 21127766
    [No Abstract]   [Full Text] [Related]  

  • 5. What are the emerging therapeutic alternatives to warfarin in stroke patients? How would the results of RE-LY benefit Pakistanis?
    Khan M; Raza E; Kamal AK
    J Pak Med Assoc; 2011 Jun; 61(6):612-3. PubMed ID: 22204226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Improvements in oral anticoagulant therapy for atrial fibrillation].
    Briongos Figuero S; García Santos-Gallego C; Badimón JJ
    Med Clin (Barc); 2013 Dec; 141(11):487-93. PubMed ID: 23597953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should dabigatran replace warfarin for stroke prevention in AF?
    Drug Ther Bull; 2011 Oct; 49(10):114-7. PubMed ID: 21994438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial.
    Paikin JS; Haroun MJ; Eikelboom JW
    Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):279-86. PubMed ID: 21438804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation: A promising new anticoagulant for stroke prevention.
    Spinler SA
    Nat Rev Cardiol; 2010 Jan; 7(1):10-1. PubMed ID: 20019756
    [No Abstract]   [Full Text] [Related]  

  • 10. Dabigatran: a new anticoagulant for stroke prevention in patients with atrial fibrillation.
    Weachter R
    Mo Med; 2012; 109(2):146-9. PubMed ID: 22675797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
    Roskell NS; Lip GY; Noack H; Clemens A; Plumb JM
    Thromb Haemost; 2010 Dec; 104(6):1106-15. PubMed ID: 20967400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran v warfarin. Compare with higher standard.
    Edwards D
    BMJ; 2010 Oct; 341():c5984. PubMed ID: 20978048
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.
    Khoo CW; Lip GY
    Expert Opin Pharmacother; 2010 Mar; 11(4):685-7. PubMed ID: 20105114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dabigatran versus Warfarin in patients with atrial fibrillation. Results of the RE-LY study].
    Liakishev AA
    Kardiologiia; 2009; 49(10):75-6. PubMed ID: 19845524
    [No Abstract]   [Full Text] [Related]  

  • 15. Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation.
    Schwartz NE; Albers GW
    Stroke; 2010 Jun; 41(6):1307-9. PubMed ID: 20395603
    [No Abstract]   [Full Text] [Related]  

  • 16. Dabigatran versus warfarin in patients with atrial fibrillation.
    Tomoda H
    N Engl J Med; 2009 Dec; 361(27):2671-2; author reply 2674-5. PubMed ID: 20050382
    [No Abstract]   [Full Text] [Related]  

  • 17. Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
    Ezekowitz MD; Wallentin L; Connolly SJ; Parekh A; Chernick MR; Pogue J; Aikens TH; Yang S; Reilly PA; Lip GY; Yusuf S;
    Circulation; 2010 Nov; 122(22):2246-53. PubMed ID: 21147728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dabigatran: beyond the RE-LY study].
    García Alegría J
    Rev Clin Esp; 2012 Mar; 212 Suppl 2():1-3. PubMed ID: 23117715
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran versus warfarin for patients with non-valvular atrial fibrillation: is the patient the winner?
    Grave S
    Aust Nurs J; 2011 Dec-2012 Jan; 19(6):30-3. PubMed ID: 22329103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.